Opinion|Videos|April 4, 2025
Future Breakthroughs: What’s Next for Bispecific Antibodies in Oncology?
Experts discuss innovations and advancements in bispecific antibodies that could transform their use in the next 5 years.
Advertisement
Episodes in this series
Video content above is prompted by the following:
What innovations or advancements in bispecific antibodies could transform their use in the next 5 years?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
4
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
5
